New two-pronged therapy could prolong survival time in glioblastoma patients
(11/10/17 5:53am)
The median survival time for glioblastoma—the most aggressive form of brain cancer—is a mere 15 months. A new Duke study, however, could help give glioblastoma patients more time than that.